A detailed history of Nemes Rush Group LLC transactions in Incyte Corp stock. As of the latest transaction made, Nemes Rush Group LLC holds 645 shares of INCY stock, worth $44,401. This represents 0.01% of its overall portfolio holdings.

Number of Shares
645
Previous 28 2203.57%
Holding current value
$44,401
Previous $1.7 Million 2065.35%
% of portfolio
0.01%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$57.33 - $68.61 $35,372 - $42,332
617 Added 2203.57%
645 $36.7 Million
Q2 2024

Aug 15, 2024

SELL
$51.18 - $63.75 $31,578 - $39,333
-617 Reduced 95.66%
28 $1.7 Million
Q1 2024

May 15, 2024

BUY
$56.55 - $66.59 $36,474 - $42,950
645 New
645 $36.7 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.3B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Nemes Rush Group LLC Portfolio

Follow Nemes Rush Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nemes Rush Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nemes Rush Group LLC with notifications on news.